Skip to main content

Next-Generation Vaccines Eradicating Chronic and Infectious Diseases


The growing prevalence of chronic and infectious disorders such as cancer, and diabetes, globally has emerged as the biggest concerns that the medical industry faces today. There have been continuous attempts to develop improved treatment procedures for such diseases.
Vaccines have been one of the most effective methods for the treatment and prevention of diseases. The invention of DNA, recombinant, and cancer vaccines, and advancements in the platform for vaccine delivery have transformed the conventional therapeutic and preventive vaccines and are playing an important role in the treatment of such chronic diseases.
At present, the vaccine market is in its growing stage, however as per the market intelligence report published by BIS Research titled “Global Vaccine Market – Analysis and Forecast (2018 – 2028),” the vaccine market is anticipated to witness tremendous growth at 11.0% during the forecast period, 2018 – 2028 and generate $103.57 billion in the revenue by 2028.
This high growth of the market can be attributed to the increasing incidences of chronic diseases, growing adoption of vaccines across developed as well as developing countries, and the invention of advanced techniques and technologies.  Amongst the long list of advantages of vaccines, the reduced healthcare cost and improved life expectancy rate are their major benefits.
Several leading pharmaceutical companies are venturing in the market, some of these include Abbott Laboratories, Bavarian Nordic, CSL Limited, Emergent BioSolutions Inc., Johnson & Johnson, Merck & Company Inc., and Madison Vaccines Incorporated.
The report published by BIS Research discusses the vaccine market under different segments on the basis of type, disease type, and region. Under the vaccine type, there are subunit and conjugate, live attenuated, inactivated, recombinant, toxoid, and next-generation vaccines. Moreover, the disease type segment includes cancer, hepatitis, rotavirus, varicella, and influenza, among others.
Under the region segment, the report analyzes the market for North America, Europe, Asia-Pacific, Latin America, and Middle East Africa. Amongst these, Asia-Pacific region is expected to grow at the fastest CAGR during the forecast period.
With technological advancements in the medical industry, vaccines for multiple cancers such as gastric, ovarian, melanoma, and prostate cancer have already been developed and several companies at present are focusing to develop next-generation vaccines. The global vaccine market in the coming years is expected to evolve and undergo various developments and advancements.

Comments

Post a Comment

Popular posts from this blog

Personal Care Ingredients Market Size, Share & Trends Analysis Report 2019-2029

The introduction and proliferation of bio-based ingredients in several industries, such as food and beverage, pharmaceuticals, and cosmetics, has been transforming the manufacturing landscape since 2000. Growing consumer inclination toward the adoption of bio-based products due to rising health and environmental concerns is driving the demand for bio-based ingredients in the cosmetics and personal care products. Besides, awareness among consumers regarding the harmful effects of synthetic ingredients chemicals has grown rapidly over the past years. In addition, the availability of green raw materials has also urged large cosmetic firms to develop bio-based cosmetic products. However, limited availability of raw material, due to erratic weather conditions and stringent environmental regulations, can pose substantial hurdles in the production of bio-based ingredients. Thus, leading companies have been focusing on developing new and sustainable ways of producing the ingredi...
Post a Comment
Read more

Agriculture Technology-as-a-Service Market Research, Trends and Forecast To 2026

As agriculture becomes a lucrative high-technology industry, professionals with new-age skill sets, companies, and investing bodies are being drawn in rapidly.  The development in smart agriculture technologies has not only led to advancements in the production capabilities of farmers but has also introduced transformative business models in the industry. Report Overview is Available at: https://bisresearch.com/industry-report/agriculture-technology-service-market-report.html As the entire agriculture industry incorporates and experiences the growth of these agriculture technologies into the farming cycle, it also faces the challenges associated with its adoption. One of the major restraining factors associated with the adoption is the large capital investments required for its acquisition and operation. Most of the farming communities across the world do not have a strong financial background to execute significant capital formation. Since prices for technologically advanced farm ...
Post a Comment
Read more

Liquid Biopsy, North America, and Lung Cancer Occupying a Major Share in the Market

  Owing to the market availability of large number of liquid biopsy technologies, the liquid biopsy segment currently accounts for a dominating share in the global minimally invasive biopsy technologies market . However, the market growth in the segment can be attributed to the increasing demand for liquid biopsy and the strong product pipeline. For instance, CNI Second Opinion by Chronix Biomedical is presently under development and is expected to get launched during the forecast period 2019-2030. Owing to a widespread market presence of leading players and the huge prevalence of cancer, North America presently holds a major share in the global minimally invasive biopsy technologies market. According to the World Cancer Research Fund (WCRF), with an estimated 2 million cases in 2018, lung cancer is the most commonly occurring cancer in men and third-most commonly occurring cancer in women. Due to the widespread presence of cancer, the manufacturers including Biocept, Inc., Chron...
Post a Comment
Read more